AUTL logo

Autolus Therapeutics plc American Depositary Share


AUTL: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.


Show AUTL Financials

Consumer Interest
SEC Filings

Recent trades of AUTL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by AUTL's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of AUTL in WallStreetBets Daily Discussion


Recent insights relating to AUTL

CNBC Recommendations

Recent picks made for AUTL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AUTL

Corporate Flights

Flights by private jets registered to AUTL